---

Highlights of January 2021

1. Intas Pharma inks licensing agreement with Alteogen to develop new products.
2. Bharat Biotech in pact with GSK, PATH to manufacture world's only malaria vaccine.
3. ADQ picks up minority stake in India Major Biocon Biologics for US$75 Million.
4. Serum Institute of India to partner with Novavax to launch another COVID-19 vaccine 'Covovax' by June 2021.
5. Bharat Biotech inks pact with Precisa Med to supply Covaxin to Brazil.
6. Pfizer invests US$25 Million in Vedanta Biosciences.
7. Thermo Fisher picks up Novasep's viral vector business for US$878 Million outright.
8. Philips to buy medical device integrator Capsule Technologies for US$635 Million.
9. Haemonetics to buy bloodstopper medtech Cardiva Medical in US$510 Million deal.
10. Charles River Laboratories spends US$83 Million to snap up Distributed Bio to boost antibody work.
11. Komodo Health to acquire Mavens after undisclosed US$44 Million VC round.
12. Boehringer inks collaboration with Enara Bio.

Highlights at Aagami:

• Aagami successfully completed JP Morgan Healthcare Conference & Biotech Showcase (digital) in January 2021 with 35+ one-to-one partnering meetings.
• Aagami is celebrating its 18th Anniversary by offering special pricing to its clients (Offer period Dec 2020 – Feb 2021, please contact us for more details).